You are here:
Dominik Modest becomes Managing Director and new…
“Together, we can make significant advances in…
What drives people to actively shape cancer…
At this year's annual reception, the German Cancer…
Würzburg, Germany – Biostatistics plays a key…
The first patient in the Phase I clinical trial…
Advanced, hard-to-treat cancers are among the…
The NCT is a long-term cooperation between the…
On July 1st, an international scientific symposium…
Personalized Oncology Begins with Diagnosis and…
